Feedback / Questions
acamprosate sustained release (SF 999) - Confluence Pharmaceuticals LLC, AOP Orphan Pharma
https://fragilexnewstoday.com/2019/04/30/confluence-gets-200k-from-university-affiliated-venture-fund-to-develop-fragile-x-treatment/
May 1, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev